Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Cancer Biomarkers Market Research Report 2016

  • QYR720584
  • 106 Pages
  • October 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Production, means the output of Cancer Biomarkers

Revenue, means the sales value of Cancer Biomarkers

This report studies Cancer Biomarkers in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Abbott Laboratories (U.S.)

Affymetrix Inc. (U.S.)

Roche Diagnostics Ltd. (Switzerland)

Illumina, Inc. (U.S.)

Qiagen NV (Netherlands)

Agilent Technologies (U.S.)

Thermo Fisher Scientific Inc. (U.S.)

Merck & Co. Inc. (U.S.)

Becton Dickinson and Company (U.S.)

Hologic Inc. (U.S.)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Cancer Biomarkers in these regions, from 2011 to 2021 (forecast), like

North America

Europe

China

Japan

Southeast Asia

India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

Protein Biomarkers

Genetic Biomarkers

Others

Split by application, this report focuses on consumption, market share and growth rate of Cancer Biomarkers in each application, can be divided into

Diagnostics

Drug Discovery and Development

Prognostics

Risk Assessment

Others?

Table of Contents

Global Cancer Biomarkers Market Research Report 2016

1 Cancer Biomarkers Market Overview

1.1 Product Overview and Scope of Cancer Biomarkers

1.2 Cancer Biomarkers Segment by Type

1.2.1 Global Production Market Share of Cancer Biomarkers by Type in 2015

1.2.2 Protein Biomarkers

1.2.3 Genetic Biomarkers

Others

1.3 Cancer Biomarkers Segment by Application

1.3.1 Cancer Biomarkers Consumption Market Share by Application in 2015

1.3.2 Diagnostics

1.3.3 Drug Discovery and Development

1.3.4 Prognostics

1.3.5 Risk Assessment

1.3.6 Others?

1.4 Cancer Biomarkers Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Cancer Biomarkers (2011-2021)

2 Global Cancer Biomarkers Market Competition by Manufacturers

2.1 Global Cancer Biomarkers Production and Share by Manufacturers (2015 and 2016)

2.2 Global Cancer Biomarkers Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Cancer Biomarkers Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Cancer Biomarkers Manufacturing Base Distribution, Sales Area and Product Type

2.5 Cancer Biomarkers Market Competitive Situation and Trends

2.5.1 Cancer Biomarkers Market Concentration Rate

2.5.2 Cancer Biomarkers Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Cancer Biomarkers Production, Revenue (Value) by Region (2011-2016)

3.1 Global Cancer Biomarkers Production by Region (2011-2016)

3.2 Global Cancer Biomarkers Production Market Share by Region (2011-2016)

3.3 Global Cancer Biomarkers Revenue (Value) and Market Share by Region (2011-2016)

3.4 Global Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

3.5 North America Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

3.6 Europe Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

3.7 China Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Japan Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

3.9 Southeast Asia Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

3.10 India Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Cancer Biomarkers Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Cancer Biomarkers Consumption by Regions (2011-2016)

4.2 North America Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Cancer Biomarkers Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Cancer Biomarkers Production, Revenue (Value), Price Trend by Type

5.1 Global Cancer Biomarkers Production and Market Share by Type (2011-2016)

5.2 Global Cancer Biomarkers Revenue and Market Share by Type (2011-2016)

5.3 Global Cancer Biomarkers Price by Type (2011-2016)

5.4 Global Cancer Biomarkers Production Growth by Type (2011-2016)

6 Global Cancer Biomarkers Market Analysis by Application

6.1 Global Cancer Biomarkers Consumption and Market Share by Application (2011-2016)

6.2 Global Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Cancer Biomarkers Manufacturers Profiles/Analysis

7.1 Abbott Laboratories (U.S.)

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Cancer Biomarkers Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Abbott Laboratories (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 Affymetrix Inc. (U.S.)

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Cancer Biomarkers Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 Affymetrix Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Roche Diagnostics Ltd. (Switzerland)

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Cancer Biomarkers Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 Illumina, Inc. (U.S.)

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Cancer Biomarkers Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 Illumina, Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Qiagen NV (Netherlands)

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Cancer Biomarkers Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Qiagen NV (Netherlands) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Agilent Technologies (U.S.)

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Cancer Biomarkers Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Agilent Technologies (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Thermo Fisher Scientific Inc. (U.S.)

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Cancer Biomarkers Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 Merck & Co. Inc. (U.S.)

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 Cancer Biomarkers Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 Merck & Co. Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 Becton Dickinson and Company (U.S.)

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 Cancer Biomarkers Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 Becton Dickinson and Company (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

7.10 Hologic Inc. (U.S.)

7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

7.10.2 Cancer Biomarkers Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 Hologic Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2015 and 2016)

7.10.4 Main Business/Business Overview

8 Cancer Biomarkers Manufacturing Cost Analysis

8.1 Cancer Biomarkers Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Cancer Biomarkers

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Cancer Biomarkers Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Cancer Biomarkers Market Forecast (2016-2021)

12.1 Global Cancer Biomarkers Production, Revenue Forecast (2016-2021)

12.2 Global Cancer Biomarkers Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Cancer Biomarkers Production Forecast by Type (2016-2021)

12.4 Global Cancer Biomarkers Consumption Forecast by Application (2016-2021)

12.5 Cancer Biomarkers Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures

Figure Picture of Cancer Biomarkers

Figure Global Production Market Share of Cancer Biomarkers by Type in 2015

Figure Product Picture of Protein Biomarkers

Table Major Manufacturers of Protein Biomarkers

Figure Product Picture of Genetic Biomarkers

Table Major Manufacturers of Genetic Biomarkers

Figure Product Picture of Others

Table Major Manufacturers of Others

Table Cancer Biomarkers Consumption Market Share by Application in 2015

Figure Diagnostics Examples

Figure Drug Discovery and Development Examples

Figure Prognostics Examples

Figure Risk Assessment Examples

Figure Others? Examples

Figure North America Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Cancer Biomarkers Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Cancer Biomarkers Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Cancer Biomarkers Capacity of Key Manufacturers (2015 and 2016)

Table Global Cancer Biomarkers Capacity Market Share by Manufacturers (2015 and 2016)

Figure Global Cancer Biomarkers Capacity of Key Manufacturers in 2015

Figure Global Cancer Biomarkers Capacity of Key Manufacturers in 2016

Table Global Cancer Biomarkers Production of Key Manufacturers (2015 and 2016)

Table Global Cancer Biomarkers Production Share by Manufacturers (2015 and 2016)

Figure 2015 Cancer Biomarkers Production Share by Manufacturers

Figure 2016 Cancer Biomarkers Production Share by Manufacturers

Table Global Cancer Biomarkers Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Cancer Biomarkers Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Cancer Biomarkers Revenue Share by Manufacturers

Table 2016 Global Cancer Biomarkers Revenue Share by Manufacturers

Table Global Market Cancer Biomarkers Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Cancer Biomarkers Average Price of Key Manufacturers in 2015

Table Manufacturers Cancer Biomarkers Manufacturing Base Distribution and Sales Area

Table Manufacturers Cancer Biomarkers Product Type

Figure Cancer Biomarkers Market Share of Top 3 Manufacturers

Figure Cancer Biomarkers Market Share of Top 5 Manufacturers

Table Global Cancer Biomarkers Capacity by Regions (2011-2016)

Figure Global Cancer Biomarkers Capacity Market Share by Regions (2011-2016)

Figure Global Cancer Biomarkers Capacity Market Share by Regions (2011-2016)

Figure 2015 Global Cancer Biomarkers Capacity Market Share by Regions

Table Global Cancer Biomarkers Production by Regions (2011-2016)

Figure Global Cancer Biomarkers Production and Market Share by Regions (2011-2016)

Figure Global Cancer Biomarkers Production Market Share by Regions (2011-2016)

Figure 2015 Global Cancer Biomarkers Production Market Share by Regions

Table Global Cancer Biomarkers Revenue by Regions (2011-2016)

Table Global Cancer Biomarkers Revenue Market Share by Regions (2011-2016)

Table 2015 Global Cancer Biomarkers Revenue Market Share by Regions

Table Global Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Table China Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Table India Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Cancer Biomarkers Consumption Market by Regions (2011-2016)

Table Global Cancer Biomarkers Consumption Market Share by Regions (2011-2016)

Figure Global Cancer Biomarkers Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Cancer Biomarkers Consumption Market Share by Regions

Table North America Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)

Table Europe Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)

Table China Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)

Table Japan Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)

Table India Cancer Biomarkers Production, Consumption, Import & Export (2011-2016)

Table Global Cancer Biomarkers Production by Type (2011-2016)

Table Global Cancer Biomarkers Production Share by Type (2011-2016)

Figure Production Market Share of Cancer Biomarkers by Type (2011-2016)

Figure 2015 Production Market Share of Cancer Biomarkers by Type

Table Global Cancer Biomarkers Revenue by Type (2011-2016)

Table Global Cancer Biomarkers Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Cancer Biomarkers by Type (2011-2016)

Figure 2015 Revenue Market Share of Cancer Biomarkers by Type

Table Global Cancer Biomarkers Price by Type (2011-2016)

Figure Global Cancer Biomarkers Production Growth by Type (2011-2016)

Table Global Cancer Biomarkers Consumption by Application (2011-2016)

Table Global Cancer Biomarkers Consumption Market Share by Application (2011-2016)

Figure Global Cancer Biomarkers Consumption Market Share by Application in 2015

Table Global Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)

Figure Global Cancer Biomarkers Consumption Growth Rate by Application (2011-2016)

Table Abbott Laboratories (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Abbott Laboratories (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Laboratories (U.S.) Cancer Biomarkers Market Share (2011-2016)

Table Affymetrix Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Affymetrix Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Figure Affymetrix Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)

Table Roche Diagnostics Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Figure Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Market Share (2011-2016)

Table Illumina, Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Illumina, Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Figure Illumina, Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)

Table Qiagen NV (Netherlands) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Qiagen NV (Netherlands) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Figure Qiagen NV (Netherlands) Cancer Biomarkers Market Share (2011-2016)

Table Agilent Technologies (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Agilent Technologies (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Figure Agilent Technologies (U.S.) Cancer Biomarkers Market Share (2011-2016)

Table Thermo Fisher Scientific Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Figure Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)

Table Merck & Co. Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck & Co. Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Figure Merck & Co. Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)

Table Becton Dickinson and Company (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Becton Dickinson and Company (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Figure Becton Dickinson and Company (U.S.) Cancer Biomarkers Market Share (2011-2016)

Table Hologic Inc. (U.S.) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Hologic Inc. (U.S.) Cancer Biomarkers Production, Revenue, Price and Gross Margin (2011-2016)

Figure Hologic Inc. (U.S.) Cancer Biomarkers Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cancer Biomarkers

Figure Manufacturing Process Analysis of Cancer Biomarkers

Figure Cancer Biomarkers Industrial Chain Analysis

Table Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015

Table Major Buyers of Cancer Biomarkers

Table Distributors/Traders List

Figure Global Cancer Biomarkers Production and Growth Rate Forecast (2016-2021)

Figure Global Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)

Table Global Cancer Biomarkers Production Forecast by Regions (2016-2021)

Table Global Cancer Biomarkers Consumption Forecast by Regions (2016-2021)

Table Global Cancer Biomarkers Production Forecast by Type (2016-2021)

Table Global Cancer Biomarkers Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370